Serotonergic involvement in haloperidol-induced catalepsy

Journal of Pharmacology and Experimental Therapeutics

Volumn 265, Issue 1, 1993, Pages 207-217

  Neal Beliveau, B S ^a   Joyce, J N ^a   Lucki, I ^a  

^a 111 Clinical Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; APOMORPHINE; BROLAMFETAMINE; BUSPIRONE; DOPAMINE 2 RECEPTOR; FENFLURAMINE; HALOPERIDOL; KETANSERIN; MIANSERIN; PINDOLOL; RECEPTOR SUBTYPE; SEROTONIN 1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1C RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG SELECTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; CATALEPSY; HALOPERIDOL; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SUPPORT, U.S. GOV'T, P.H.S.; SYNAPTIC TRANSMISSION;

EID: 0027527435     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)